Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: jk28 who wrote (735)	8/4/1999 11:11:00 PM
From: Sunny Jim	Read Replies (1) \| Respond to of 1139

ICOS is a good company but it all depends on where this market is going. With a little consolidation, we could see ICOS back in the mid-20's along with the rest of the market. Aside from the general market tho, what ICOS needs is a successful trial announcement after the recent Pafase bomb. Does anybody know what the timeframe for the ongoing trials is, ie, are any results expected in the next month or so. I was hoping that we would hear something on the IC351 MED trials but that one seems to have cooled down - talk about missing a market window. Do I sound kind of disappointed here? No news is not good news.